Pregnancy Clinical Trial
— LIFTOfficial title:
LIFT: Lifestyle Interventions For Two (Member of the LIFE Moms Consortium)
Verified date | January 2019 |
Source | Columbia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomized, controlled trial is proposed to study the effect, in a cohort of racially and ethnically diverse group of overweight and obese pregnant women, of an Intensive Lifestyle Intervention (ILI) which utilize cognitive behavioral strategies to help participants achieve and maintain changes in dietary intake and physical activity habits compared to Usual Care (UC) on gestational weight gain (GWG), infant fatness, and mothers' post-delivery weight retention. The hypothesis is that the percent body fat at birth will be significantly less in offspring from ILI mothers than UC mothers.
Status | Completed |
Enrollment | 210 |
Est. completion date | August 31, 2017 |
Est. primary completion date | August 31, 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Singleton viable pregnancy - Gestational age between 9,0 and 15,6 - Body Mass Index of 25 and above - Age 18 and over - Ability to contact Exclusion Criteria: - Less than 18 years old - Diagnosis of Diabetes or Hemoglobin A1c (HbA1c)> or = 6.5% - Known fetal anomaly - Planned termination of pregnancy - History of 3 more more consecutive first trimester miscarriages - Current eating disorder - Actively suicidal - Prior or planned bariatric surgery - Current use of metformin, systemic steroids, antipsychotic agents, anti-seizure medications, mood stabilizers, attention deficit hyperactivity disorder medications - Continued use of weight loss medication - Contraindications to aerobic exercise in pregnancy - Participation in another interventional study that influences weight control - Enrollment in this trial in a previous pregnancy - Intention of the participant or of the care provider for the delivery to be outside the Lifestyle Interventions For Expectant (LIFE) Moms consortium hospital - Participant's unwillingness or inability to commit to a 1 year follow-up of herself or her child, including planning to move away - Smoking - History of Drug and/or Alcohol Addiction - Chronic health problems that prohibit regular exercise or known to influence body composition - Other chronic disease as determined by investigators - Claustrophobia (only for participants who elect to have MRI) - Implanted metal objects that render MRI unsafe (only for participants who elect to have MRI) - Lack of support from primary health care provider or family members - Another member of the household is a study participant or staff member - Any other medical, psychiatric, social or behavioral factor that in the judgement of the Principal Investigator (PI) may interfere with study participation or ability to follow the intervention protocol |
Country | Name | City | State |
---|---|---|---|
United States | Columbia University Medical Center | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Columbia University | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Infant Percent Fat at Birth | Infant % fat at birth as a continuous variable. This will be ascertained from PeaPod within 24 hours after birth. | Within 24 hours of birth | |
Secondary | Mother fat mass gain 35 Weeks | Fat mass gain of mother at 35,0-35,6 weeks of pregnancy as a continuous variable. | 35,0-35,6 weeks of pregnancy | |
Secondary | Mother fat mass gain one year postpartum | Mother's fat mass at 52 (range 48-56) weeks postpartum | 48-56 weeks postpartum | |
Secondary | Mother's weight one-year postpartum | Weight of mother at 52 (range 48-56) weeks | 48-56 weeks postpartum | |
Secondary | Infant % fat 14 weeks | Infant %fat at 14 (range 13-15) weeks. This will be ascertained from PeaPod. | 13-15 weeks | |
Secondary | Infant % fat 52 weeks | Infant %fat 52 (range 48-56) weeks. | 48-52 weeks | |
Secondary | Infant Weight 14 weeks | Infant weight at 14 (range 13-15) weeks. | 13-15 weeks | |
Secondary | Infant weight 52 weeks | Infant weight at 52 (range 48-56) weeks. | 48-56 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A |